CWM
MDT icon

Castle Wealth Management’s Medtronic MDT Stock Holding History

Castle Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-414
Closed -$34K – 404
2022
Q3 		$34K Buy
414
+101
+32% +$9.08K 0.02% 262
2022
Q2 		$28K Buy
+313
New +$31.7K 0.02% 283

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Castle Wealth Management's MDT Position: Q4 2022 in Review

Castle Wealth Management sold out of Medtronic (MDT) in Q4 2022, closing a stake of 414 shares — an estimated $34K sold.

Castle Wealth Management first reported a position in MDT in Q2 2022 and held it in 2 quarters. The position peaked at $34K in Q3 2022. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Castle Wealth Management reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • Castle Wealth Management sold 414 Medtronic shares in Q4 2022, an estimated $34K.
  • Castle Wealth Management first reported a position in Medtronic in Q2 2022 and held it in 2 quarters.
  • Castle Wealth Management's Medtronic position peaked at $34K in Q3 2022.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Castle Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.